Cargando…
Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predicti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567529/ https://www.ncbi.nlm.nih.gov/pubmed/34786389 http://dx.doi.org/10.12998/wjcc.v9.i30.9070 |
_version_ | 1784594254192967680 |
---|---|
author | Zhong, Ting-Ting Wang, Gang Wang, Xiao-Qin Kong, Wei-Dan Li, Xiao-Yu Xue, Qian Zou, Yu-An |
author_facet | Zhong, Ting-Ting Wang, Gang Wang, Xiao-Qin Kong, Wei-Dan Li, Xiao-Yu Xue, Qian Zou, Yu-An |
author_sort | Zhong, Ting-Ting |
collection | PubMed |
description | BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predictive value of serum calcium, albumin, globulin and matrix metalloproteinase-9 (MMP-9) levels for HT after intravenous thrombolysis (IVT) in patients with acute cerebral infarction. METHODS: Five hundred patients with acute cerebral infarction who received IVT with alteplase within 4.5 h after the onset of disease between January 2018 and January 2021 at our hospital were selected as the study subjects. They were divided into groups based on computed tomography scan results of the brain made within 36 h after thrombolysis. Forty patients with HT were enrolled in an observation group and 460 patients without HT were enrolled in a control group. Serum calcium, albumin, globulin and MMP-9 levels were compared between the two groups. Regression analysis was used to discuss the relationship between these indices and HT. RESULTS: The previous history of hypertension, diabetes, atrial fibrillation, cerebrovascular diseases, smoking and alcohol intake were not associated with HT after IVT in patients with acute cerebral infarction (all P > 0.05). The National Institutes of Health stroke scale (NHISS) score was associated with HT after IVT in patients with acute cerebral infarction (P < 0.05). The serum calcium and albumin levels were lower in the observation group than in the control group (all P < 0.05). The levels of globulin and MMP-9 were significantly higher in the observation group than in the control group (all P < 0.05). Logistic regression analysis showed that NHISS score, serum calcium, albumin, globulins and MMP-9 were independent factors influencing the occurrence of HT following IVT in patients with cerebral infarction (P < 0.05). CONCLUSION: Serum calcium, albumin, globulin and MMP-9 levels are risk factors for HT after IVT in patients with acute cerebral infarction. Moreover, NHISS score can be used as a predictor of post-thrombolytic HT. |
format | Online Article Text |
id | pubmed-8567529 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-85675292021-11-15 Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients Zhong, Ting-Ting Wang, Gang Wang, Xiao-Qin Kong, Wei-Dan Li, Xiao-Yu Xue, Qian Zou, Yu-An World J Clin Cases Observational Study BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predictive value of serum calcium, albumin, globulin and matrix metalloproteinase-9 (MMP-9) levels for HT after intravenous thrombolysis (IVT) in patients with acute cerebral infarction. METHODS: Five hundred patients with acute cerebral infarction who received IVT with alteplase within 4.5 h after the onset of disease between January 2018 and January 2021 at our hospital were selected as the study subjects. They were divided into groups based on computed tomography scan results of the brain made within 36 h after thrombolysis. Forty patients with HT were enrolled in an observation group and 460 patients without HT were enrolled in a control group. Serum calcium, albumin, globulin and MMP-9 levels were compared between the two groups. Regression analysis was used to discuss the relationship between these indices and HT. RESULTS: The previous history of hypertension, diabetes, atrial fibrillation, cerebrovascular diseases, smoking and alcohol intake were not associated with HT after IVT in patients with acute cerebral infarction (all P > 0.05). The National Institutes of Health stroke scale (NHISS) score was associated with HT after IVT in patients with acute cerebral infarction (P < 0.05). The serum calcium and albumin levels were lower in the observation group than in the control group (all P < 0.05). The levels of globulin and MMP-9 were significantly higher in the observation group than in the control group (all P < 0.05). Logistic regression analysis showed that NHISS score, serum calcium, albumin, globulins and MMP-9 were independent factors influencing the occurrence of HT following IVT in patients with cerebral infarction (P < 0.05). CONCLUSION: Serum calcium, albumin, globulin and MMP-9 levels are risk factors for HT after IVT in patients with acute cerebral infarction. Moreover, NHISS score can be used as a predictor of post-thrombolytic HT. Baishideng Publishing Group Inc 2021-10-26 2021-10-26 /pmc/articles/PMC8567529/ /pubmed/34786389 http://dx.doi.org/10.12998/wjcc.v9.i30.9070 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Observational Study Zhong, Ting-Ting Wang, Gang Wang, Xiao-Qin Kong, Wei-Dan Li, Xiao-Yu Xue, Qian Zou, Yu-An Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title | Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title_full | Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title_fullStr | Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title_full_unstemmed | Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title_short | Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
title_sort | serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567529/ https://www.ncbi.nlm.nih.gov/pubmed/34786389 http://dx.doi.org/10.12998/wjcc.v9.i30.9070 |
work_keys_str_mv | AT zhongtingting serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT wanggang serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT wangxiaoqin serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT kongweidan serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT lixiaoyu serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT xueqian serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients AT zouyuan serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients |